ACO Name and Location
A2 ACO LLC
Trade Name/DBA: Baptist Health/UAMS Accountable Care Alliance
10825 Financial Centre Parkway, Suite 410, Little Rock, AR, 72211, U.S.A.
ACO Primary Contact
Primary Contact Name: Jasmin Sumrall, BH UAMS Accountable Care Alliance Executive Director
Primary Contact Phone Number: 501-202-2260
Primary Contact Email Address: jasmin.sumrall@baptist-health.org
Organizational Information
ACO participants:
| ACO Participants | ACO Participant in Joint Venture |
| Arkansas Health Group | N |
| Baptist Health | N |
| Baptist Health Extended Care Hospital-Little Rock, Inc. | N |
| Baptist Health Hospitals | N |
| Baptist Health Regional Hospitals | N |
| Baptist Health Services | N |
| Baptist MedCare Inc. | N |
| Conway Community Services | N |
| University Of Arkansas For Medical Sciences | N |
| Carmical Medical PLLC | N |
ACO governing body:
| Member First Name | Member Last Name | Member Title/Position | Member's Voting Power | Membership Type | ACO Participant Legal Business Name, if Applicable |
|---|---|---|---|---|---|
| Amanda | George, CPA | Board Member | 11.11% | ACO Participant Representative | University of Arkansas for Medical Sciences |
| Brent | Beaulieu, CPA | Board Member | 11.11% | ACO Participant Representative | Baptist Health |
| Cliff | Fullerton, MD | Board Member | 11.12% | ACO Participant Representative | Baptist Health |
| Gregory | Sharp, MD | Board Member | 11.11% | ACO Participant Representative | Arkansas Health Group |
| Herbert | Hahn, MD | Board Member | 11.11% | ACO Participant Representative | Baptist Health |
| Jerry | Baugh | Board Member | 11.11% | Medicare Beneficiary Representative | N/A |
| Michelle | Kruase, MD | Board Member | 11.11% | ACO Participant Representative | University of Arkansas for Medical Sciences |
| Priya | Mendiratta, MD | Board Member | 11.11% | ACO Participant Representative | University of Arkansas for Medical Sciences |
| Shashank | Kraleti, MD | Board Member | 11.11% | ACO Participant Representative | University of Arkansas for Medical Sciences |
Member’s voting power may have been rounded to reflect a total voting power of 100 percent.
Key ACO clinical and administrative leadership:
| ACO Executive Director & Compliance Officer | Jasmin Sumrall, MPH |
| Medical Director & Quality Assurance/Improvement Officer | Riley Lipschitz, MD |
Associated Committees and Committee Leadership
| Committee Name | Committee Leader Name and Position |
| Clinical Quality Committee | Riley Lipschitz, MD, Baptist Health, Chief Medical Officer for Population Health (Committee Chair) Stephen Foster, MD, University of Arkansas for Medical Sciences |
| Nominating Committee | Michelle Krause, MD, University of Arkansas for Medical Sciences, Senior Vice Chancellor for UAMS Health and Chief Executive Officer Brent Beaulieu, CPA, Baptist Health, Chief Financial Officer |
| Executive Committee | Cliff Fullerton, MD, Baptist Health, Chief Value Based Care Officer (Committee Chair) |
Types of ACO participants, or combinations of participants, that formed the ACO:
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
Third Agreement Period
- Performance Year 2024, $8,960,569.45
Second Agreement Period
- Performance Year 2023, $11,791,934.23
- Performance Year 2022, $12,566,063.00
First Agreement Period
- Performance Year 2021, $4,470,728.73
- Performance Year 2020, $6,541,586.53
- Performance Year 2019, $0
- Performance Year 2018, $0
Shared Savings Distribution
First Agreement Period
Performance Year 2024
- Proportion invested in infrastructure: 61%
- Proportion invested in redesigned care processes/resources: 14%
- Proportion of distribution to ACO participants: 25%
Second Agreement Period
Performance Year 2023
- Proportion invested in infrastructure: 55%
- Proportion invested in redesigned care processes/resources: 19%
- Proportion of distribution to ACO participants: 26%
Performance Year 2022
- Proportion invested in infrastructure: 56%
- Proportion invested in redesigned care processes/resources: 6%
- Proportion of distribution to ACO participants: 38%
First Agreement Period
Performance Year 2021
- Proportion invested in infrastructure: 20%
- Proportion invested in redesigned care processes/resources: 47%
- Proportion of distribution to ACO participants: 33%
Performance Year 2020
- Proportion invested in infrastructure: 55%
- Proportion invested in redesigned care processes/resources: 45%
- Proportion of distribution to ACO participants: 0%
Performance Year 2019
- Proportion invested in infrastructure: N/A%
- Proportion invested in redesigned care processes/resources: N/A%
- Proportion of distribution to ACO participants: N/A%
Performance Year 2018
- Proportion invested in infrastructure: N/A%
- Proportion invested in redesigned care processes/resources: N/A%
- Proportion of distribution to ACO participants: N/A%
Quality Performance Results
2024 Quality Performance Results
Quality performance results are based on the CMS Web Interface collection type.
| Measure # | Measure Name | Collection Type | Rate | ACO Mean |
|---|---|---|---|---|
| 321 | CAHPS for MIPS | CMS Web Interface | 7.15 | 6.67 |
| 479* | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups [1] | Administrative Claims | 0.1588 | 0.1517 |
| 484* | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1] | Administrative Claims | - | 37.00 |
| 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 64.98 | 88.99 |
| 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 71.83 | 68.60 |
| 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 53.85 | 79.98 |
| 113 | Colorectal Cancer Screening | CMS Web Interface | 80.73 | 77.81 |
| 112 | Breast Cancer Screening | CMS Web Interface | 77.09 | 80.93 |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 84.77 | 86.50 |
| 370 | Depression Remission at Twelve Months | CMS Web Interface | 24.55 | 17.35 |
| 001* | Diabetes: Hemoglobin A1c (HbA1c) Poor Control [1] | CMS Web Interface | 7.59 | 9.44 |
| 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 69.39 | 81.46 |
| 236 | Controlling High Blood Pressure | CMS Web Interface | 75.31 | 79.49 |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CMS Web Interface | 87.60 | 83.70 |
| CAHPS-2 | How Well Providers Communicate | CMS Web Interface | 94.11 | 93.96 |
| CAHPS-3 | Patient's Rating of Provider | CMS Web Interface | 93.04 | 92.43 |
| CAHPS-4 | Access to Specialists | CMS Web Interface | 79.79 | 75.76 |
| CAHPS-5 | Health Promotion and Education | CMS Web Interface | 60.28 | 65.48 |
| CAHPS-6 | Shared Decision Making | CMS Web Interface | 64.00 | 62.31 |
| CAHPS-7 | Health Status and Functional Status | CMS Web Interface | 74.50 | 74.14 |
| CAHPS-8 | Care Coordination | CMS Web Interface | 86.99 | 85.89 |
| CAHPS-9 | Courteous and Helpful Office Staff | CMS Web Interface | 92.67 | 92.89 |
| CAHPS-11 | Stewardship of Patient Resources | CMS Web Interface | 23.31 | 26.98 |
For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day,
All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and
Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple
Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure
performance.
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple
Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying
Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and
ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs
may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of
these ACOs do not have a performance rate calculated due to not meeting the minimum of 18
beneficiaries attributed to non-QP providers.
Payment Rule Waivers
- Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.